ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,450,304 | +24.9% | 35,757 | +1.7% | 0.03% | +20.8% |
| Q3 2022 | $1,161,000 | +6.2% | 35,143 | +13.2% | 0.02% | +14.3% |
| Q2 2022 | $1,093,000 | -24.1% | 31,047 | -0.9% | 0.02% | -4.5% |
| Q1 2022 | $1,441,000 | -40.6% | 31,326 | -14.3% | 0.02% | -37.1% |
| Q4 2021 | $2,424,000 | -22.4% | 36,557 | -3.0% | 0.04% | -28.6% |
| Q3 2021 | $3,123,000 | 0.0% | 37,705 | 0.0% | 0.05% | +19.5% |
| Q2 2021 | $3,123,000 | +33.1% | 37,705 | +6.5% | 0.04% | +17.1% |
| Q1 2021 | $2,347,000 | -56.9% | 35,392 | -50.1% | 0.04% | -58.3% |
| Q4 2020 | $5,442,000 | +246.8% | 70,920 | +94.6% | 0.08% | +211.1% |
| Q3 2020 | $1,569,000 | – | 36,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |